198,732 HCA Healthcare, Inc. $HCA Shares Sold by Curated Wealth Partners LLC

Key Points

• Curated Wealth Partners LLC cut its HCA Healthcare position by 99.7% in the third quarter, selling 198,732 shares and retaining 544 shares worth approximately $232,000. Institutional investors collectively own 62.73% of HCA stock.
• Wall Street maintains a “Moderate Buy” consensus, with 16 Buy, seven Hold, and one Sell rating and an average price target of $467.61. Recent targets range from $387 to $495.
• HCA reported quarterly revenue of $20.23 billion and earnings of $7.59 per share, exceeding analyst estimates, while revenue increased 8.7% year over year. The company also paid a quarterly dividend of $0.78 per share, representing a 0.7% yield.

Curated Wealth Partners LLC trimmed its position in HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 99.7% during the 3rd quarter, according to its most recent Form 13F filing with the SEC. The fund owned 544 shares of the company's stock after selling 198,732 shares during the period. Curated Wealth Partners LLC's holdings in HCA Healthcare were worth $232,000 as of its most recent SEC filing.

Several other institutional investors have also recently made changes to their positions in the business. Cedar Mountain Advisors LLC bought a new stake in HCA Healthcare during the first quarter valued at approximately $33,000. MidFirst Bank bought a new position in HCA Healthcare in the second quarter worth approximately $28,000. Clearstead Trust LLC purchased a new position in shares of HCA Healthcare during the 2nd quarter worth $29,000. Delos Wealth Advisors LLC bought a new stake in shares of HCA Healthcare during the 2nd quarter valued at $35,000. Finally, Merkkuri Wealth Advisors LLC bought a new stake in shares of HCA Healthcare during the 1st quarter valued at $43,000. Institutional investors own 62.73% of the company's stock.

Wall Street Analysts Forecast Growth

HCA has been the topic of a number of recent research reports. BMO Capital Markets began coverage on HCA Healthcare in a report on Tuesday, September 22nd. They issued an "outperform" rating and a $495.00 target price on the stock. The Goldman Sachs Group cut their price target on HCA Healthcare from $558.00 to $485.00 and set a "buy" rating for the company in a report on Tuesday, July 28th. JPMorgan Chase & Co. decreased their price objective on HCA Healthcare from $490.00 to $425.00 and set a "neutral" rating on the stock in a research note on Thursday, August 20th. Deutsche Bank Aktiengesellschaft set a $476.00 price objective on HCA Healthcare in a research report on Monday, July 27th. Finally, Barclays reduced their target price on shares of HCA Healthcare from $402.00 to $387.00 and set an "equal weight" rating for the company in a report on Monday, July 27th. Sixteen research analysts have rated the stock with a Buy rating, seven have given a Hold rating and one has given a Sell rating to the company's stock. According to MarketBeat, HCA Healthcare currently has an average rating of "Moderate Buy" and an average target price of $467.61.

HCA Healthcare Stock Performance

Shares of HCA Healthcare stock opened at $458.39 on Monday. HCA Healthcare, Inc. has a fifty-two week low of $353.99 and a fifty-two week high of $556.52. The company has a market capitalization of $99.24 billion, a P/E ratio of 15.35, a P/E/G ratio of 1.55 and a beta of 1.10. The company has a fifty day moving average of $426.39 and a 200 day moving average of $418.93.

HCA Healthcare (NYSE:HCA - Get Free Report) last posted its quarterly earnings results on Friday, July 24th. The company reported $7.59 EPS for the quarter, beating analysts' consensus estimates of $7.56 by $0.03. The business had revenue of $20.23 billion for the quarter, compared to analysts' expectations of $19.76 billion. HCA Healthcare had a negative return on equity of 244.79% and a net margin of 8.77%. The business's quarterly revenue was up 8.7% on a year-over-year basis. During the same period last year, the firm earned $6.84 earnings per share. Analysts forecast that HCA Healthcare, Inc. will post 29.45 EPS for the current year.

HCA Healthcare Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Wednesday, September 30th. Shareholders of record on Wednesday, September 16th were paid a $0.78 dividend. This represents a $3.12 annualized dividend and a yield of 0.7%. The ex-dividend date was Wednesday, September 16th. HCA Healthcare's dividend payout ratio is presently 10.45%.

HCA Healthcare Company Profile

HCA Healthcare, Inc is a healthcare services company that operates hospitals, ambulatory surgery centers, emergency care facilities, physician practices and other healthcare sites. Its facilities provide a broad range of services, including acute and emergency care, surgery, cardiology, oncology, women's and children's services, behavioral health and outpatient care.

The company serves patients primarily across the United States through a network of healthcare facilities in numerous states.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.